-
Recent Posts
- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
- Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
- Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) Spikes on Earnings but is there More to the Numbers?
- Is Gold in the Future for FBC Holding, Inc. (OTCQB: FBCD)?
- Will it be Clear Sailing for Alas International Holdings, Inc. (PINKSHEETS: VDSC)?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Category Archives: AMEX
Can Richmont Mines, Inc. (AMEX: RIC) Rebound from Disappointing Third Quarter Results?
On November 8, 2012 Richmont Mines Inc. (AMEX: RIC) stated in their third quarter results that, “In the near-to-medium term, we will continue to focus on maximizing productivity, enhancing mine sequencing and increasing recovered grades at our operating mines, and … Continue reading
Posted in AMEX, Articles
Tagged exploration, gold, gold price, gold production, gold property, investors, ric, richmont mines
Leave a comment
Can Inovio Pharmaceuticals, Inc. (AMEX: INO) Realize Potential with Multiple Synthetic Vaccines for Wide Range of Medical Issues?
After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading
Posted in AMEX, Articles
Tagged biotechnology, cancer, cmv, hiv, hpv, ino, inovio pharmaceuticals, investors, medical issues, virus
Leave a comment
Versar Inc. (AMEX: VSR) Starting October Strong after a Slow September, Contract with USACE is the Catalyst
With news that the company had been awarded the Afghanistan Personal Services Contract for the U.S. Army Corps of Engineers (USACE) shares of Versar Inc. (AMEX: VSR) spiked to a 52-week high of 4.24 on Monday before closing the day … Continue reading
Posted in AMEX, Articles
Tagged afghanistan, construction management, environmental services, investors, usace, versar inc, vsr
Leave a comment
Is American Apparel, Inc. (AMEX: APP) Capable of Winning Back Investor Confidence with Positive Outlook?
Back in 2011 American Apparel, Inc. (AMEX: APP) Chairman and CEO Dov Charney stated “We have solid plans to drive increased sales through existing and new channels. We are also diligently working on improving our return on invested capital through … Continue reading
Posted in AMEX, Articles
Tagged american apparel, app, branded fashion, dov cherney, investors, outlook, retail, same store sales
Leave a comment
Can Rentech, Inc. (AMEX: RTK) Find Profitability with Conversion of Syngas into Complex Hydrocarbons for Fuels?
Shares of Rentech, Inc. (AMEX: RTK) hit a three month high of 2.18 on Wednesday, two days before the clean energy technology company is scheduled to release their second quarter 2012 earnings report. While shares of RTK dipped slightly to … Continue reading
Posted in AMEX, Articles
Tagged biomass gasification, hydrocarbons, investors, natural gas, petroleum, rentech, rtk, syngas
Leave a comment
Vringo, Inc. (AMEX: VRNG) Attracting Plenty of Attention with Patent Infringement Lawsuit Against Google, Inc. (NASDAQ: GOOG) Nearing
The buzz surrounding Vringo, Inc. (AMEX: VRNG) continues to get louder as their October 16, 2012 court date against Google, Inc. (NASDAQ: GOOG) draws nearer, inspiring investors and leading many analysts to kick up astronomical figures that could potentially be … Continue reading
Entertainment Gaming Asia Inc. (AMEX: EGT) Ready to Expand Their Casino Presence with Electronic Gaming Machines Agreements
On Monday shares of Entertainment Gaming Asia Inc. (AMEX: EGT) climbed to a 52-week high of 0.65 before closing the day at 0.62 on trading volume that exceeded 2.3 million. It was an impressive spike for EGT given the fact … Continue reading
Posted in AMEX, Articles
Tagged casino, egt, electronic gaming machines, entertainment gaming asia, investors, slot hall, tables
Leave a comment
Vringo, Inc. (AMEX: VRNG) Attracting Investors with Mobile Social and Video Applications, Merger Agreement
After sinking to a 52-week low of 0.68 back on January 25, 2012 shares of Vringo, Inc. (AMEX: VRNG), a provider of software platforms for mobile social and video applications, have spiked considerably, touching 2.14 on Wednesday following their announced … Continue reading
Posted in AMEX, Articles
Tagged aol, apps, facebook, facetones, google, investors, mobile social, video applications, vringo, vrng
Leave a comment
CEL-SCI Corporation (AMEX: CVM) Remains an Intriguing Bet for Investors Interested in Biotech’s Treatment for Head and Neck Cancer
With the dust settling following last month’s financing deal in which CEL-SCI Corporation (AMEX: CVM) sold 16,000,000 shares of its common stock to institutional investors for $5,760,000 or $0.36 per share, along with those institutional investors receiving Series H warrants … Continue reading
Posted in AMEX, Articles
Tagged biotech, cancer, cel-sci, cvm, fda, head and neck cancer, investors, multikine, teva pharma, tumors
Leave a comment


